Soup Capital Exchange Upgrades Trading Engine to Process Over 500,000 Orders per Second

Soup Capital Exchange Upgrades Trading Engine to Process Over 500,000 Orders per Second GlobeNewswire September 22, 2025 Denver, CO, Sept. 22, 2025 (GLOBE NEWSWIRE) — Soup Capital LTD, a fintech innovator based in Denver, today announced a major upgrade to its flagship product, Soup Capital Exchange, unveiling a next-generation trading engine capable of processing over […]

Advent Technologies Delivers State-of-the-Art Portable Fuel Cell Systems under Contract with the U.S. Department of Defense

Advent Technologies Delivers State-of-the-Art Portable Fuel Cell Systems under Contract with the U.S. Department of Defense GlobeNewswire September 22, 2025 LIVERMORE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) — Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in fuel cells and hydrogen technologies, has delivered its next generation, state-of-the-art Honey Badger 50(TM) (“HB50”) portable power

Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration

Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration GlobeNewswire September 22, 2025 Screening closing ahead of expectations, with full enrollment now anticipated in 4Q 2025 (previously 1Q 2026) ARTEMIS topline data readout accelerated to 1Q 2027 REDWOOD CITY, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE)

The Oncology Institute Achieves $1.1 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 2 through its California Professional Corporation

The Oncology Institute Achieves $1.1 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 2 through its California Professional Corporation Practice earns maximum quality points on avoidable ED visits and admissions, saving more than $3,500 per episode GlobeNewswire September 22, 2025 CERRITOS, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) — The Oncology Institute of

MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)

MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast) ~Patient Recruitment Closed~ GlobeNewswire September 22, 2025 LA JOLLA, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875),

Slide Added to Russell 2000(R) Index

Slide Added to Russell 2000(R) Index GlobeNewswire September 22, 2025 TAMPA, Fla., Sept. 22, 2025 (GLOBE NEWSWIRE) — Slide Insurance Holdings, Inc. (“Slide” or the “Company”) (Nasdaq: SLDE) today announced that it has joined the Russell 2000(R) Index, effective at the open of US equity markets on Monday, September 22, 2025 as part of the

SemiCab Wins Prestigious Logistics Award, Industry Recognition for Best Value Award

SemiCab Wins Prestigious Logistics Award, Industry Recognition for Best Value Award GlobeNewswire September 22, 2025 Company Wins Best Value Award at LogiMeet 2025 Fort Lauderdale, FL, Sept. 22, 2025 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME), an AI technology holding company announced today that its subsidiary, SemiCab Holdings, LLC (“SemiCab”), recently won the

LifeVantage to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

LifeVantage to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 GlobeNewswire September 22, 2025 SALT LAKE CITY, Sept. 22, 2025 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife,

Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting

Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting Presentation Highlighted Data Supporting Clinical Benefit of GTx-104 Compared to Orally Administered Nimodipine in the Treatment of aneurysmal Subarachnoid Hemorrhage (aSAH) GlobeNewswire September 22, 2025 PRINCETON, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) — Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics

Lancaster Resources Secures District-Scale Expansion, Doubling Footprint at Lake Cargelligo Gold Project to 62,300 hectares

Lancaster Resources Secures District-Scale Expansion, Doubling Footprint at Lake Cargelligo Gold Project to 62,300 hectares GlobeNewswire September 22, 2025 VANCOUVER, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) — Lancaster Resources Inc. (CSE:LCR) (OTCPink:LANRF) (FRA:6UF) (“Lancaster“), is pleased to announce that it has acquired additional mineral claims at the 100% owned Lake Cargelligo Gold Project in

Scroll to Top